Join
Codex DNA Inc. logo

DNAY

NASDAQ

Codex DNA Inc.

SectorHealth CareIndustryMedical SpecialitiesIPO2021
$1.20-0.06 (-4.76%)
News25/Ratings5

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries. The company also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Latest news

25 items

DNAY FAQ

7 questions
  • What does Codex DNA Inc. do?
    Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly...
  • Where does DNAY stock trade?
    Codex DNA Inc. (DNAY) is listed on NASDAQ.
  • What sector and industry is DNAY in?
    Codex DNA Inc. operates in the Health Care sector, Medical Specialities industry.
  • When did Codex DNA Inc. go public?
    Codex DNA Inc. (DNAY) completed its IPO in 2021.
  • What are analysts saying about DNAY?
    Codex DNA Inc. has had 5 recent analyst actions on file. The most recent action was from Cowen: Outperform on 2022-03-02. Recent price targets range from $2300.00 to $3000.00.
  • What companies are similar to DNAY?
    Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare DNAY side-by-side with any of them on Quantisnow.
  • How can I track DNAY on Quantisnow?
    Quantisnow aggregates Codex DNA Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DNAY to receive live email and push alerts on every new disclosure.